Elicio Therapeutics, Inc. Common Stock
Symbol: ELTX (NASDAQ)
11.83
▲ (1.76%) 0.205
Company Description:
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
Key Stats
- Today's Open: $11.64
- Today's High: $11.825
- Today's Low: $11.58
- Today's Volume: 10.95K
- Yesterday Close: $11.62
- Yesterday High: $11.71
- Yesterday Low: $11.25
- Yesterday Volume: 33.53K
- Last Min Volume: 30
- Last Min High: $11.825
- Last Min Low: $11.825
- Last Min VWAP: $11.825
Company Profile
- Name: Elicio Therapeutics, Inc. Common Stock
- Website: https://www.elicio.com
- Listed Date: 2023-06-02
- Location: BOSTON, MA
- Market Status: Active
- CIK Number: 0001601485
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $191.16M
- Round Lot: 100
- Outstanding Shares: 16.34M
- Asset Type: CS
RECENT FILINGS FOR ELTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-12 | 8-K | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-08-05 | 8-K | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | SCHEDULE 13D/A | View |
| 2025-06-04 | 8-K | View |
| 2025-05-20 | 4 | View |
| 2025-05-20 | 4 | View |
| 2025-05-20 | 4 | View |
| 2025-05-20 | 4 | View |
| 2025-05-20 | 4 | View |
| 2025-05-20 | 4 | View |
| 2025-05-20 | 4 | View |
| 2025-05-20 | 8-K | View |
| 2025-05-14 | SCHEDULE 13G/A | View |
| 2025-05-13 | 10-Q | View |
| 2025-05-13 | 8-K | View |
| 2025-04-16 | 4 | View |
| 2025-04-09 | ARS | View |
Latest News on ELTX